Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,200 HIV / AIDS
clinical trials

Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018/PNEU-WAY)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Crofoot Research Center, Inc. ( Site 0118)
mi
from
Houston, TX
Click here to add this to my saved trials
Primary Immunodeficiency Disease Clinical Trial
Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Octapharma Research Site
mi
from
Centennial, CO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Impact of HIV-1 and Aging on Mucosal Vaccine Responses
Status: Enrolling, Phase IV
Updated: 12/31/1969
Rocky Mountain Regional VA Medical Center
mi
from
Aurora, CO
Click here to add this to my saved trials
HIV Clinical Trial
HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC (University of Pittsburgh Medical Center)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
Safety, Pharmacokinetics, and Antiviral Activity of GS-6207 Administered Subcutaneously in HIV-1 Infected Adults
Status: Enrolling, Phase I
Updated: 12/31/1969
Ruane Clinical Research Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Consent for Use of Stored Patient Specimens for Future Testing
Status: Enrolling, Phase
Updated: 12/31/1969
The Research & Education Group-Portland CRS (31474)
mi
from
Portland, OR
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
1182.58.61005 Royal Prince Alfred Hospital
mi
from
Camperdown,
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
Florida Center for Pediatric Cellular Therapy
mi
from
Orlando, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Bellaire, TX
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Status: Enrolling, Phase III
Updated: 12/31/1969
Capital Digestive Care
mi
from
Washington DC,
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I
Updated: 12/31/1969
Saint Vincent's Hospital
mi
from
Darlinghurst,
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Bellaire, TX
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Rialto, CA
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Miami Springs, FL
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Norwalk, CT
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Center of Translational AIDS Research, Lewis Katz School of Medicine at Temple University CRS
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Southampton Healthcare, Inc. CRS
mi
from
Saint Louis, MO
Click here to add this to my saved trials
HIV INfections Clinical Trial
Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants
Status: Enrolling, Phase I
Updated: 12/31/1969
University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program
mi
from
La Jolla, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Puerto Rico Pediatric HIV/AIDS Research Program CRS
mi
from
San Juan,
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Malcom Randall VA Medical Center CRS
mi
from
Gainesville, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
Clinical Research Facility
mi
from
Balitmore, MD
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases, Musculoskeletal, Psychiatry / Psychology Clinical Trial
Treating Comorbid Pain and Depression in HIV+ Individuals
Status: Enrolling, Phase III
Updated: 12/31/1969
Hennepin Healthcare
mi
from
Minneapolis, MN
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Adolescent & Young Adult Research at The CORE Center (AYAR at CORE)
mi
from
Chicago, IL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling, Phase II, III
Updated: 12/31/1969
New Orleans Adolescent Trials Unit CRS
mi
from
New Orleans, LA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Washington University Therapeutics (WT) CRS
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status: Enrolling, Phase II
Updated: 12/31/1969
Univ. of Maryland HIVTR-CCR5 Non-Network CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status: Enrolling, Phase II
Updated: 12/31/1969
UCSF HIVTR-CCR5 Non-network CRS
mi
from
San Francisco, CA
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling, Phase
Updated: 12/31/1969
Arizona Allergy & Immunology Research
mi
from
Mesa, AZ
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling, Phase
Updated: 12/31/1969
Riviera Allergy Medical Center
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1182.70.127 Health Services Center, Inc.
mi
from
Anniston, AL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1182.70.250 Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1182.70.037
mi
from
Dactur, GA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Harbor City, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1182.70.165 Comprehensive Care Center
mi
from
Nashville, TN
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Woodland Hills, CA
Click here to add this to my saved trials
HIV Clinical Trial
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Status: Enrolling, Phase II, III
Updated: 12/31/1969
CD03 Investigational site
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
HIV Clinical Trial
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Status: Enrolling, Phase II, III
Updated: 12/31/1969
CD03 Investigational site
mi
from
New Haven, CT
Click here to add this to my saved trials
HIV Clinical Trial
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Status: Enrolling, Phase II, III
Updated: 12/31/1969
CD03 Investigational site
mi
from
New York, NY
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
Early ART to Limit Infection and Establishment of Reservoir
Status: Enrolling, Phase II
Updated: 12/31/1969
Hospital Nossa Senhora da Conceicao CRS (12201)
mi
from
Porto Alegre,
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
CCTG 603: Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals (The iM-PrEPT Study)
Status: Enrolling
Updated: 12/31/1969
LA Biomed at Harbor-UCLA
mi
from
Torrance, CA
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
Biomarkers to Predict Time to Plasma HIV RNA Rebound
Status: Enrolling, Phase
Updated: 12/31/1969
Washington U CRS (2101)
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Mobile-Based Application "MyChoices"
Status: Enrolling
Updated: 12/31/1969
Fenway Health Center
mi
from
Boston, MA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Computerized Substance Use and Depression Screening and Behavioral Treatment in HIV Primary Care
Status: Enrolling, Phase
Updated: 12/31/1969
Kaiser Permanente Division of Research
mi
from
Oakland, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Maryland Medical Center Midtown Campus
mi
from
Baltimore, MD
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Triggered Escalating Real-time Adherence (TERA) Intervention
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Primary Immune Deficiency Diseases (PIDD) Clinical Trial
Study of PlasmaCap IG in Adults and Children With PIDD
Status: Enrolling, Phase III
Updated: 12/31/1969
AAICPA
mi
from
Irving, TX
Click here to add this to my saved trials
Primary Immune Deficiency Diseases (PIDD) Clinical Trial
Study of PlasmaCap IG in Adults and Children With PIDD
Status: Enrolling, Phase III
Updated: 12/31/1969
Mid Columbia Research
mi
from
Richland, WA
Click here to add this to my saved trials
Primary Immune Deficiency Diseases (PIDD) Clinical Trial
Study of PlasmaCap IG in Adults and Children With PIDD
Status: Enrolling, Phase III
Updated: 12/31/1969
Allergy Associates of the Palm Beaches, P.A.
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Immunologic Deficiency Syndromes Clinical Trial
Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Status: Enrolling, Phase III
Updated: 11/21/2017
Optimed Infusions LLC
mi
from
Columbus, OH
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Romidepsin Plus 3BNC117 Phase 2a Study
Status: Enrolling, Phase II
Updated: 12/18/2017
Aarhus University Hospital
mi
from
Aarhus,
Click here to add this to my saved trials
HIV Clinical Trial
Innovative Approaches for Minor Consent: Consent 2.0
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado/Univ of Colorado SOM
mi
from
Aurora, CO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego
Status: Enrolling, Phase
Updated: 12/31/1969
Owen Clinic - University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Specimen Repository for HIV Immunopathogenesis
Status: Enrolling, Phase
Updated: 12/31/1969
AIDS Healthcare Foundation - Public Health Division
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
Status: Enrolling, Phase II
Updated: 12/31/1969
National Marrow Donor Program
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
Status: Enrolling, Phase I
Updated: 12/31/1969
Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Primary Immunodeficiency Disease Clinical Trial
Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Octapharma Research Site
mi
from
San Diego, CA
Click here to add this to my saved trials
HIV/AIDS Clinical Trial
A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Center for Virology and Vaccine Research/ Clinical Trials Unit/ BIDMC
mi
from
Boston, MA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Obstructive Sleep Apnea Endotypes and Impact on Phenotypes of People Living With HIV
Status: Enrolling, Phase
Updated: 12/31/1969
Altman Clinical and Translational Research Institute
mi
from
San Diego, CA
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
Safety, Pharmacokinetics, and Antiviral Activity of GS-6207 Administered Subcutaneously in HIV-1 Infected Adults
Status: Enrolling, Phase I
Updated: 12/31/1969
AIDS Arms, Inc. DBA Prism Health North Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
Consent for Use of Stored Patient Specimens for Future Testing
Status: Enrolling, Phase
Updated: 12/31/1969
Penn Therapeutics CRS (6201)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Status: Enrolling, Phase IV
Updated: 12/31/1969
Hosp. General de Agudos Buenos Aires Argentina NICHD CRS
mi
from
Ciudad de Buenos Aires,
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents
Status: Enrolling, Phase I, II
Updated: 12/31/1969
WNE Maternal Pediatric Adolescent AIDS CRS
mi
from
Worcester, MA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology, Other Clinical Trial
IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents
Status: Enrolling
Updated: 7/13/2015
San Juan City Hosp. PR NICHD CRS (5031)
mi
from
San Juan,
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University/St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases, Ophthalmology, Other, Reproductive Clinical Trial
Natural History Study of SCID Disorders
Status: Enrolling, Phase
Updated: 12/31/1969
Alberta Children's Hospital
mi
from
Calgary,
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
1 … 12 13 14 15 16 17 18 19 20 21 22